stockrow
Friday 6 November 2026
Export ELMD’s income statement to Excel — free account
Electromed, Inc.
ELMD Healthcare Medical Devices
Electromed, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $73.8 million, up 15.3% from fiscal 2025.
- Revenue
- +11.6%
- EPS
- +57.7%
- Free cash flow
- −25.2%
Quarter to June 2026, against a year earlier
26.90
0.13
+0.49%
Follow ELMD
Alert me
Electromed, Inc. (ELMD) P/E ratio
As of 5 November 2026, Electromed, Inc. (ELMD) trades at a P/E ratio of 19.4×. Over the past ten years it has ranged from 7.9× (January 2016) to 138× (January 2015); the current reading is higher than 15% of that period. That is below the Medical Devices industry median of 25.6× and below the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 30.9× | 23.56% |
| FY2025 | 25.0× | 5.96% |
| FY2024 | 23.6× | (16.32%) |
| FY2023 | 28.2× | (18.14%) |
| FY2022 | 34.4× | (14.61%) |
| FY2021 | 40.3× | 28.38% |
| FY2020 | 31.4× | 42.49% |
| FY2019 | 22.0× | (6.12%) |
| FY2018 | 23.5× | 14.63% |
| FY2017 | 20.5× | 43.26% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 30.9× | 60.91% |
| Mar 2026 | 19.2× | (29.49%) |
| Dec 2025 | 27.2× | 7.53% |
| Sep 2025 | 25.3× | 1.28% |
| 42 more quarters | Free account |
Against its own ten years
Low 7.9×
High 138×
Ten-year median
25.8×
Current reading's percentile
9
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| RXST RxSight, Inc. compare | n/m |
| INGN Inogen, Inc compare | n/m |
| STIM Neuronetics, Inc. compare | n/m |
| QSI Quantum-Si Incorporated compare | n/m |
| TLSI TriSalus Life Sciences, Inc. compare | n/m |
| PROF Profound Medical compare | n/m |
| LAB Standard BioTools Inc. compare | 1.8× |
| ELMD Electromed, Inc. | 19.4× |
| INFU InfuSystems Holdings, Inc. compare | 32.0× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)